CAMBRIDGE, Mass., June 13, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman, President and Chief Executive Officer, will present a corporate overview at the 2018 JMP Securities Life Sciences Conference, being held in New York City on June 20-21, 2018. JMP Securities Life Sciences Conference – Leap Presentation Details: Date: Wednesday, June...